No Data
No Data
Lifetech Sci (01302.HK) will hold a board of directors meeting on August 30th to approve the interim performance.
Lifetech sci (01302.HK) announced on August 12 that the board of directors will hold a meeting on August 30, 2024 to review and approve the company and its subsidiaries' mid-year performance up to June 30, 2024, and to propose the distribution of mid-term dividends, if any.
LIFETECH SCI: NOTICE OF BOARD MEETING
Are LifeTech Scientific Corporation's (HKG:1302) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
Sinolink Securities: The pharmaceutical sector is expected to see an improvement in market conditions in the third quarter, and overall growth expectations for the second half of the year are optimistic.
Sinolink Securities released a research report stating that considering the improvement in the medical insurance settlement cycle, the expectation of policy improvement, and the recovery performance of the industry, as well as the fact that institutional medicine hold positions are at a low level, the medical sector will usher in an improved market situation in Q3.
LIFETECH SCI: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THEANNUAL RESULTS ANNOUNCEMENT AND ANNUAL REPORTFOR THE YEAR ENDED 31 DECEMBER 2023
No Data